Ionis' 'breakthrough' Alexander disease approval establishes pillar of rare disease pipeline

Ionis Pharmaceuticals received FDA approval for Zanvastro (zilganersen), the first drug to treat Alexander disease, a rare genetic disorder. This approval marks a major milestone for Ionis' neurology pipeline and sets a precedent for accelerating other rare pediatric disease therapies.

This Wire brief sits within Fusion42's coverage of Biotech, and 15 sources have reported it between 3 Sep 2026 and 22 Sep 2026.